Phase 1 Clinical study of ABS-201 for androgenic alopecia.
Latest Information Update: 04 Apr 2025
At a glance
- Drugs ABS 201 (Primary)
- Indications Alopecia
- Focus Adverse reactions
- 04 Apr 2025 New trial record
- 18 Mar 2025 According to Absci media release, the company is planning to initiate Phase 1 clinical trial for ABS-201 in early 2026.